Curcuminoid-Tailored Interfacial Free Energy of Hydrophobic Fibers for Enhanced Biological Properties.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
02 Jun 2021
Historique:
pubmed: 25 5 2021
medline: 19 8 2021
entrez: 24 5 2021
Statut: ppublish

Résumé

The ability of mimicking the extracellular matrix architecture has gained electrospun scaffolds a prominent space into the tissue engineering field. The high surface-to-volume aspect ratio of nanofibers increases their bioactivity while enhancing the bonding strength with the host tissue. Over the years, numerous polyesters, such as poly(lactic acid) (PLA), have been consolidated as excellent matrices for biomedical applications. However, this class of polymers usually has a high hydrophobic character, which limits cell attachment and proliferation, and therefore decreases biological interactions. In this way, functionalization of polyester-based materials is often performed in order to modify their interfacial free energy and achieve more hydrophilic surfaces. Herein, we report the preparation, characterization, and

Identifiants

pubmed: 34024099
doi: 10.1021/acsami.1c05034
pmc: PMC8289194
doi:

Substances chimiques

Diarylheptanoids 0
Polyesters 0
poly(lactide) 459TN2L5F5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24493-24504

Références

ACS Appl Mater Interfaces. 2020 Apr 29;12(17):19345-19356
pubmed: 32252517
ACS Appl Mater Interfaces. 2020 Nov 18;12(46):51212-51224
pubmed: 33153261
In Vitro Cell Dev Biol Anim. 2020 Apr;56(4):313-321
pubmed: 32307668
Molecules. 2015 Aug 05;20(8):14293-311
pubmed: 26251892
Sci Rep. 2018 Aug 20;8(1):12472
pubmed: 30127347
J Agric Food Chem. 2010 Oct 27;58(20):11130-9
pubmed: 20925386
Polymers (Basel). 2018 Dec 27;11(1):
pubmed: 30960018
Nanomedicine. 2018 Aug;14(6):1753-1763
pubmed: 29778889
Bioact Mater. 2021 Jan 28;6(8):2412-2438
pubmed: 33553825
Small. 2020 Mar;16(11):e1907422
pubmed: 32068968
ACS Appl Mater Interfaces. 2021 Jan 13;13(1):48-66
pubmed: 33356093
Mater Sci Eng C Mater Biol Appl. 2020 Dec;117:111314
pubmed: 32919674
J Biomed Mater Res B Appl Biomater. 2005 Jan 15;72(1):156-65
pubmed: 15389493
Nat Prod Rep. 2011 Nov;28(12):1937-55
pubmed: 21979811
Colloids Surf B Biointerfaces. 2021 Mar;199:111525
pubmed: 33373844
ACS Appl Mater Interfaces. 2020 Sep 23;12(38):42891-42901
pubmed: 32840994
Philos Trans A Math Phys Eng Sci. 2016 Aug 6;374(2073):
pubmed: 27354732
Curr Neuropharmacol. 2013 Jul;11(4):338-78
pubmed: 24381528
Biomed Mater. 2012 Aug;7(4):045001
pubmed: 22556150
Science. 2007 Dec 7;318(5856):1618-22
pubmed: 18063796
Org Biomol Chem. 2016 Jan 28;14(4):1311-24
pubmed: 26660280
Colloids Surf B Biointerfaces. 2007 Nov 15;60(2):137-57
pubmed: 17683921
Biomaterials. 2021 Feb;269:120643
pubmed: 33434713
J Cell Biochem. 2019 Sep;120(9):15410-15421
pubmed: 31069851
J Colloid Interface Sci. 2011 Jan 15;353(2):335-55
pubmed: 20846662
Nanomaterials (Basel). 2020 Dec 24;11(1):
pubmed: 33374248
Springerplus. 2016 Jul 22;5(1):1147
pubmed: 27504245
Colloids Surf B Biointerfaces. 2017 Jul 1;155:544-552
pubmed: 28494433
Photochem Photobiol. 1994 Mar;59(3):295-302
pubmed: 8016208
Neurosci Lett. 2011 Feb 11;489(3):192-6
pubmed: 21167259
Pharmaceutics. 2021 Jan 30;13(2):
pubmed: 33573313
ACS Appl Mater Interfaces. 2020 Oct 14;12(41):45673-45701
pubmed: 32937068
ACS Appl Mater Interfaces. 2020 Jul 15;12(28):31162-31171
pubmed: 32573197
Acta Pharm. 2017 Sep 1;67(3):385-395
pubmed: 28858834
Molecules. 2020 Mar 19;25(6):
pubmed: 32204372
Int J Biol Macromol. 2021 Mar 15;173:251-266
pubmed: 33476622
Adv Funct Mater. 2013 Aug 7;23(29):3628-3637
pubmed: 25309305
J Org Chem. 2013 May 3;78(9):4446-55
pubmed: 23586613
Neural Regen Res. 2012 Feb 25;7(6):405-12
pubmed: 25774181
J Biomed Mater Res B Appl Biomater. 2008 Jan;84(1):34-48
pubmed: 17477388
Acta Pharmacol Sin. 2015 May;36(5):544-52
pubmed: 25891083
ACS Appl Mater Interfaces. 2021 Mar 3;13(8):9589-9603
pubmed: 33595284
Membranes (Basel). 2020 Nov 05;10(11):
pubmed: 33167539
Materials (Basel). 2019 Mar 13;12(6):
pubmed: 30871217
Cell Reprogram. 2019 Jun;21(3):152-161
pubmed: 31145652

Auteurs

Wevernilson F de Deus (WF)

Instituto Científico e Tecnológico, Universidade Brasil, Rua Carolina Fonseca 235, 08230-030, São Paulo, São Paulo, Brazil.

Bruna M de França (BM)

Instituto de Química, Universidade Federal do Rio de Janeiro, Centro de Tecnologia, Bloco A, Cidade Universitária, 21941-909, Rio de Janeiro, Rio de Janeiro, Brazil.

Josué Sebastian B Forero (JSB)

Instituto de Química, Universidade Federal do Rio de Janeiro, Centro de Tecnologia, Bloco A, Cidade Universitária, 21941-909, Rio de Janeiro, Rio de Janeiro, Brazil.

Alessandro E C Granato (AEC)

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, CEP 05508-000, São Paulo, São Paulo, Brazil.

Henning Ulrich (H)

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, CEP 05508-000, São Paulo, São Paulo, Brazil.

Anelise C O C Dória (ACOC)

Laboratório de Biotecnologia e Plasmas Elétricos, IP&D, Universidade do Vale do Paraíba, Avenido Shishima Hifumi 2911, 12244-000, São José dos Campos, São Paulo, Brazil.

Marcello M Amaral (MM)

Instituto Científico e Tecnológico, Universidade Brasil, Rua Carolina Fonseca 235, 08230-030, São Paulo, São Paulo, Brazil.

Adam Slabon (A)

Department of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius väg 16C, 10691 Stockholm, Sweden.

Bruno V M Rodrigues (BVM)

Instituto Científico e Tecnológico, Universidade Brasil, Rua Carolina Fonseca 235, 08230-030, São Paulo, São Paulo, Brazil.
Department of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius väg 16C, 10691 Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH